|
|
|
|
B-035 / B-035-1ML updated item number format
Buprenorphine-3ß-D-glucuronide
100 ug/mL in Methanol | Certified Reference Material
|
|
Buprenorphine glucuronide is a major urinary metabolite of the semi-synthetic opioid, buprenorphine. This Certified Spiking Solution® is suitable for use in LC/MS or GC/MS applications for clinical toxicology, forensic analysis, urine drug testing, or pain prescription monitoring. Buprenorphine is used for the management of moderate chronic pain and for the treatment of opioid addiction.
|
|
|
|
|
| Concentration:
|
100 ug/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
101224-22-0
|
| Chemical Formula:
|
C35H49NO10
|
| Molecular Weight:
|
643.76
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| B-044 / B-044-1ML |
|
Buprenorphine, 1.0 mg/mL
|
|
$151.00
|
|
|
|
|
|
| B-060 / B-060-1ML |
|
Buprenorphine-D4-3-β-D-glucuronide, 100 μg/mL
|
|
$336.00
|
|
|
|
|
|
| B-901 / B-901-1ML |
|
Buprenorphine-D4, 100 μg/mL
|
|
$46.10
|
|
|
|
|
|
| B-902 / B-902-1ML |
|
Buprenorphine, 100 μg/mL
|
|
$27.70
|
|
|
|
|
|
| B-908 / B-908-1ML |
|
Buprenorphine-D4, 1.0 mg/mL
|
|
$396.00
|
|
|
|
|
|
| N-045 / N-045-1ML |
|
Norbuprenorphine glucuronide, 100 μg/mL
|
|
$279.00
|
|
|
|
|
|
| N-059 / N-059-1ML |
|
Norbuprenorphine, 1.0 mg/mL
|
|
$421.00
|
|
|
|
|
|
| N-097 / N-097-1ML |
|
Norbuprenorphine glucuronide-D3, 100 µg/mL
|
|
$301.00
|
|
|
|
|
|
| N-912 / N-912-1ML |
|
Norbuprenorphine, 100 μg/mL
|
|
$38.10
|
|
|
|
|
|
| N-920 / N-920-1ML |
|
Norbuprenorphine-D3, 100 μg/mL
|
|
$46.10
|
|
|
|
|
|
| N-921 / N-921-1ML |
|
Norbuprenorphine-D3, 1.0 mg/mL
|
|
$396.00
|
|
|
|
|
|
| P-071 / P-071-1ML |
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
|
$441.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1055 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
3822.90.0000
|
▶ Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ LC/MS (TOF) Analysis of Opioid Drugs and Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm HILIC after SPE using Supel™-Select HLB, ß-Glucuronidase Enzyme Digestion | Sigma-Aldrich®, 2014
|
|
▶ LC/MS Analysis of Opioid Glucuronide Metabolites in Urine on Ascentis® Express 2.7 µm F5 after Solid Phase Extraction (SPE) using Supel™-Select HLB | Sigma-Aldrich®, 2014
|
|
▶ Ultrafast Analysis of Buprenorphine and Norbuprenorphine in Urine Using the Agilent RapidFire High-Throughput Mass Spectrometry System | Mohamed Youssef and Vaughn P. Miller, Agilent Technologies, Inc., 2013
|
|
▶ Using UHPLC/MS (TOF) for Detection of Drugs and Metabolites in Urine following Optimized Enzymatic Hydrolysis Conditions | Sigma-Aldrich®, 2015
|
|
|
|
|